Literature DB >> 7298845

Elevated cholesterol and bile acid synthesis in an adult patient with homozygous familial hypercholesterolemia. Reduction by a high glucose diet.

P W Stacpoole, S M Grundy, L L Swift, H L Greene, A E Slonim, I M Burr.   

Abstract

Elevated levels of cholesterol synthesis are reported for several young children with homozygous familial hypercholesterolemia (HFH) and are considered to contribute directly to their hypercholesterolemia. In contrast, increased cholesterol production has not previously been found in adult patients with HFH. Using the fecal steroid balance technique, we studied rates of cholesterol and bile acid synthesis in a 24-yr-old man who had severe hypercholesterolemia typical of HFH and who lacked skin fibroblast low density lipoprotein (LDL) receptor activity. On an average diet (45% carbohydrate, 40% fat, 15% protein) mean +/- SEM cholesterol (24.8 +/- 1.4 mg/kg per d) and bile acid (11.1 +/- 1.6 mg/kg per d) excretion were approximately threefold higher than normal. When an isocaloric high carbohydrate, low fat diet (90.5% glucose oligosaccharides, 1.3% safflower oil, 8.2% crystalline amino acids was substituted, mean cholesterol (13.0 +/- 0.5 mg/kg per d) and bile acid (8.6 +/- 0.4 mg/kg per d) fell markedly. The decline in fecal steroid excretion was accompanied by modest reductions in plasma total and LDL cholesterol concentrations and by a softening of cutaneous xanthomata. Although the patient phenotypically and biochemically resembled the HFH state, his family pedigree was not noteable for hypercholesterolemia. While the patient's father had premature cardiovascular disease, his mother had no evidence of heart disease, had normal plasma total and LDL cholesterol levels, and had normal fibroblast LDL receptor activity. Likewise, the plasma cholesterol levels of three other members of the patient's family were normal. Despite the unusual genotypic background of this individual, however, the fecal balance data shows that elevated cholesterol and bile acid synthesis may occur in adult, as well as juvenile, patients with HFH and may be responsive to dietary control.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298845      PMCID: PMC370910          DOI: 10.1172/jci110361

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL DIETARY AND FECAL NEUTRAL STEROIDS.

Authors:  T A MIETTINEN; E H AHRENS; S M GRUNDY
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

2.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS.

Authors:  S M GRUNDY; E H AHRENS; T A MIETTINEN
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

3.  The metabolism of the apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinaemia in the homozygous form.

Authors:  L A Simons; D Reichl; N B Myant; M Mancini
Journal:  Atherosclerosis       Date:  1975 Mar-Apr       Impact factor: 5.162

4.  Cholesterol production in obesity.

Authors:  T A Miettinen
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

5.  Studies in the metabolism of cholesterol in subjects with normal plasma cholesterol levels and in patients with essential hypercholesterolaemia.

Authors:  B Lewis; N B Myant
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

6.  Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.

Authors:  D W Bilheimer; J L Goldstein; S M Grundy; M S Brown
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

7.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

8.  Usefulness of chromic oxide as an internal standard for balance studies in formula-fed patients and for assessment of colonic function.

Authors:  J Davignon; W J Simmonds; E H Ahrens
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

9.  Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.

Authors:  D W Bilheimer; N J Stone; S M Grundy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

10.  Portacaval shunt in four patients with homozygous hypercholesterolaemia.

Authors:  E A Stein; J Pettifor; C Mieny; K W Heimann; L Spitz; I Bersohn; I Saaron; M Dinner
Journal:  Lancet       Date:  1975-04-12       Impact factor: 79.321

View more
  1 in total

1.  Regulation of rat liver hydroxymethylglutaryl coenzyme A reductase by a new class of noncompetitive inhibitors. Effects of dichloroacetate and related carboxylic acids on enzyme activity.

Authors:  P W Stacpoole; H J Harwood; C E Varnado
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.